Breaking News
Get 50% Off 0
Final days! 🔥 Up to 50% OFF InvestingPro
CLAIM SALE
Close

Whitehawk Therapeutics Inc (WHWK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Whitehawk Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.8100 +0.1100    +6.47%
26/08 - Closed. Currency in USD
After Hours
1.8100
0.0000
0.0000%
21:10:05 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 125,163
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.7100 - 1.8350
Whitehawk Therapeutics 1.8100 +0.1100 +6.47%

Whitehawk Therapeutics Inc Company Profile

 
Get an in-depth profile of Whitehawk Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

40

Equity Type

ORD

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Contact Information

Address 2 Headquarters Plaza East Building
11th Floor Morristown, 07960
United States
Phone 551 321 2234
Fax -

Top Executives

Name Age Since Title
Pravin U. Dugel 57 2017 Independent Director
Michael T. Lotze 69 - Member of Scientific Advisory Board
Steven Prelack 64 2017 Independent Chairman
Peter A. Campochiaro - - Member of Scientific Advisory Board & Ophthalmology Advisory Board
Christopher D. Kontos - - Member of Scientific Advisory Board
Dietmar Vestweber - - Member of Scientific Advisory Board
Anupam Dalal 49 2011 Independent Director
Caley M. Castelein 50 2017 Independent Director
Cheryl L. Cohen 55 2018 Independent Director
David S. Boyer - - Member of Ophthalmology Advisory Board
Samir M. Parikh - - Member of Scientific Advisory Board
Peter K. Kaiser - - Member of Ophthalmology Advisory Board
Joseph H. Gardner 65 2011 Founder, President, Principal Executive Officer & Director
Jeffrey S. Heier 60 - Member of Ophthalmology Advisory Board
W. Daniel Stamer - - Member of Scientific Advisory Board
Neil P. Desai 60 2011 Founder & Director
Richard Maroun 70 2017 Independent Director
Anupam Dalal 53 2021 Independent Director
Emma Reeve 64 2021 Independent Director
Karin M. Hehenberger 53 2021 Independent Director
Caley M. Castelein 54 2021 Independent Chairman of the Board
Behzad Aghazadeh 54 2021 Independent Director
Mohammad Hirmand 55 2023 Independent Director
David J. Lennon 54 2023 President, CEO & Director
Baiteng Zhao 51 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

WHWK Comments

Write your thoughts about Whitehawk Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email